Cancer Research

American Association for Cancer Research

You do not currently have access to this content.
Cancer Research

American Association for Cancer Research

Cancer Res (2026) 86 (5_Supplement_2): A010.
Cancer Research

Abstract A011: Characterizing the structure of the immune checkpoint B7-H7 to optimize immune activation with targeted therapeutics

Search for other works by this author on: ...
Cancer Research

American Association for Cancer Research

Cancer Res (2025) 85 (8_Supplement_2): CT112.
Cancer Research

Abstract 393: Discovery of novel, potent and orally active GSPT1 molecular glue degraders

Abstract. Molecular glue degrader (MGD) is an emerging therapeutic strategy offering an exciting alternative to traditional small molecules exploring new target space. These small molecules interact ...
Cancer Research

Abstract 239: RCZY-690 and RCZY-680: Novel, highly potent, and orally bioavailable, tri-complex pan RAS-MULTI(ON) inhibitors with distinctive oral pharmacokinetic profiles ...

Rongchang Pharmaceuticals, Ltd., Shanghai, China.